Home › Funds › SAMLYN CAPITAL, LLC › AXSM

SAMLYN CAPITAL, LLC position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

SAMLYN CAPITAL, LLC reported holding 289,247 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$53.3M, representing 0.90% of its reported portfolio and ranking #35 among its reported holdings. SAMLYN CAPITAL, LLC has disclosed AXSM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)289.25K sh
Reported value held$53.33M
Portfolio Weight0.90%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SAMLYN CAPITAL, LLC's AXSM position evolved

SAMLYN CAPITAL, LLC first disclosed a stake in AXSM in Q2 2026 at 246,015 shares (US$60.2M). Across 2 filings, SAMLYN CAPITAL, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 289,247 shares valued at US$53.3M — an increase of 43,232 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 246.01K $60.22M New
Q3 2026 289.25K $53.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 42 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Sofinnova Investments, Inc. (US$82.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has SAMLYN CAPITAL, LLC held AXSM?

SAMLYN CAPITAL, LLC has disclosed AXSM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is SAMLYN CAPITAL, LLC's current position in AXSM?

As of Q3 2026, SAMLYN CAPITAL, LLC holds 289.25K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $53.33M, representing 0.90% of its reported portfolio and ranking #35.

Has SAMLYN CAPITAL, LLC been buying or selling AXSM?

In the latest 13F filing (Q3 2026), SAMLYN CAPITAL, LLC increased its position in AXSM.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.